|
RCHY1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.73979999999708E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.140600E-01 |
| Normal-vs-Stage2 |
2.604600E-01 |
| Normal-vs-Stage3 |
1.74149999976336E-08 |
| Normal-vs-Stage4 |
3.37060046540216E-10 |
| Stage1-vs-Stage2 |
3.778600E-01 |
| Stage1-vs-Stage3 |
3.58460000016159E-07 |
| Stage1-vs-Stage4 |
4.16500001154674E-09 |
| Stage2-vs-Stage3 |
2.453900E-02 |
| Stage2-vs-Stage4 |
5.744600E-03 |
| Stage3-vs-Stage4 |
4.273600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.968700E-04 |
| Normal-vs-AfricanAmerican |
3.762700E-04 |
| Normal-vs-Asian |
3.757600E-02 |
| Caucasian-vs-AfricanAmerican |
1.704630E-01 |
| Caucasian-vs-Asian |
7.007400E-01 |
| AfricanAmerican-vs-Asian |
9.556400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.00700000000587E-05 |
| Normal-vs-Female |
2.074400E-02 |
| Male-vs-Female |
2.042200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.629910E-02 |
| Normal-vs-Age(41-60Yrs) |
7.505000E-03 |
| Normal-vs-Age(61-80Yrs) |
1.586530E-04 |
| Normal-vs-Age(81-100Yrs) |
2.361000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.190600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.048200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.446800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.110600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.827000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.287600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.046600E-01 |
| Normal-vs-Grade 2 |
5.542600E-01 |
| Normal-vs-Grade 3 |
1.8510899999935E-05 |
| Normal-vs-Grade 4 |
1.4432899320127E-15 |
| Grade 1-vs-Grade 2 |
2.236400E-01 |
| Grade 1-vs-Grade 3 |
5.962900E-03 |
| Grade 1-vs-Grade 4 |
9.06379999943141E-08 |
| Grade 2-vs-Grade 3 |
6.579500E-04 |
| Grade 2-vs-Grade 4 |
1.39332989590457E-13 |
| Grade 3-vs-Grade 4 |
3.80390000054298E-07 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.798300E-02 |
| Normal-vs-ccB subtype |
3.82009979205122E-10 |
| ccA subtype-vs-ccB subtype |
1.65534252971611E-13 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.519200E-03 |
| Normal-vs-N1 |
9.031200E-04 |
| N0-vs-N1 |
1.839570E-02 |
|
|
